Edit |   |
---|---|
Antigenic Specificity | ganglioside GD4, Human (Ecromeximab biosimilar) |
Clone | Ecromeximab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FCM, IP, ELISA, Neut, FuncS, IF, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human Ganglioside GD4 Recombinant Antibody (Ecromeximab). Ecromeximab is a chimeric monoclonal antibody being developed for the treatment of malignant melanoma. |
Immunogen | n/a |
Other Names | Anti-Ganglioside GD4 Recombinant Antibody, Research Grade Ecromeximab, Anti-Human Ganglioside GD4 Recombinant Antibody(Ecromeximab), KM871, KW-2871, Antibody Drug Analogues, Monoclonal Antibody, YR1180, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 292819-64-8 |
Catalog # | YR1180 |
Price | please inquire |
Order / More Info | ganglioside GD4, Human (Ecromeximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |